Which has grown faster, LH or MRNA?

Over the past five years, LH grew revenue faster — LH at a -1.58% CAGR versus MRNA at -2.60%.

Does LH or MRNA pay a bigger dividend?

LH pays a dividend (1.08% yield) while MRNA does not currently pay one.

Is LH or MRNA more profitable?

LH runs the higher net margin — LH at 6.66% versus MRNA at -143.55%.

Which has been the better investment, LH or MRNA?

Over the past 5-year, LH delivered the higher annualized total return — LH at 9.60% versus MRNA at -25.58%. Past performance doesn't predict future results.

Labcorp Holdings Inc. (LH) vs Moderna, Inc. (MRNA)

LH leads on 9 of 10 compared metrics.

A side-by-side comparison of Labcorp Holdings Inc. and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Labcorp Holdings Inc.

Total return — LH vs MRNA

growth of $100 · last 8y

LH +122.0%MRNA +165.5%MRNA compounded faster

LH MRNA

LH vs MRNA: by the numbers

•LH is the larger company ($21.83B vs $19.80B market cap).
•LH is profitable (6.66% net margin) while MRNA runs a net loss (-143.55%).
•LH grew revenue faster over the past five years (-1.58% vs -2.60% CAGR).
•LH pays a dividend (1.08% yield) while MRNA does not currently pay one.

Which is better, LH or MRNA?

Metric tally: LH 9 · MRNA 1

It depends on what you're optimizing for:

GrowthLH(faster 5Y revenue CAGR)

QualityLH(higher ROIC)

Valuation

Metric	LH	MRNA
P/E ratio	23.57	—
Forward P/E	13.65	—
P/S ratio	1.56●	8.86
P/B ratio	2.53●	2.66
PEG ratio	1.28	—
EV / EBITDA	13.73	—
FCF yield	6.27%	—

Profitability

Metric	LH	MRNA
Gross margin	27.79%●	-13.89%
Operating margin	11.03%●	-153.35%
Net margin	6.66%●	-143.55%
ROE	10.79%●	-43.12%
ROIC	7.39%●	-29.70%

Dividends

Metric	LH	MRNA
Dividend yield	1.08%	—
Payout ratio	27.32%	—

Growth (annualized)

Metric	LH	MRNA
Revenue CAGR (5Y)	-1.58%●	-2.60%
EPS CAGR (5Y)	-8.00%	—
FCF CAGR (5Y)	-12.63%	126.92%●
Total return CAGR (5Y)	4.75%●	-25.58%

Frequently asked

Which is better, LH or MRNA?: It depends on your goal. growth: LH (faster 5Y revenue CAGR); quality: LH (higher ROIC). Across all compared metrics, LH leads 9 to 1.
Which has grown faster, LH or MRNA?: Over the past five years, LH grew revenue faster — LH at a -1.58% CAGR versus MRNA at -2.60%.
Does LH or MRNA pay a bigger dividend?: LH pays a dividend (1.08% yield) while MRNA does not currently pay one.
Is LH or MRNA more profitable?: LH runs the higher net margin — LH at 6.66% versus MRNA at -143.55%.
Which has been the better investment, LH or MRNA?: Over the past 5-year, LH delivered the higher annualized total return — LH at 9.60% versus MRNA at -25.58%. Past performance doesn't predict future results.

Go deeper

Full LH analysis Full MRNA analysis Interactive comparison tool

Dig into the metrics

Labcorp P/E ratio Moderna P/E ratio Labcorp dividend yield Moderna dividend yield Labcorp ROE Moderna ROE Labcorp operating margin Moderna operating margin Labcorp revenue growth Moderna revenue growth Labcorp free cash flow Moderna free cash flow

Labcorp & Moderna appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.